Trial intelligence / Profile preview

Mobile Contingency Management for Concurrent Abstinence From Cannabis and Cigarette Smoking

NCT02869451Completed

Sponsor
Duke University
Start
Aug 2016
Primary completion
May 2017
Countries
1
01

Overview

Open-label, single-arm trial in cannabis use disorder (CUD) and Tobacco Use Disorder (TUD), sponsored by Duke University. Primary endpoints: Number of Participants Who Self-report Prolonged Abstinence From Smoking at 6 months, Number of Participants Who Report Smoking Abstinence and Abstinence is Bioverified by Salivary Cotinine at 6 months and 2 more. Started Aug 2016; status: completed.

02

Conditions

cannabis use disorder (CUD)Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT02869451.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02869451.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call